CLINICAL_TRIALS
trial_result
· 2015-12-22
Clinical Trial Update: MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) [Phase 2]
Summary
This record notes the completion of Merck's Phase 2 MK0524 trial for seasonal allergic rhinitis (NCT00533208).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Seasonal Allergies | Phase 2 | Status: COMPLETED